ABM Respiratory Care

Executive Summary

ABM Respiratory Care is an Indian medical device company focused on developing innovative respiratory care solutions, including airway clearance systems (BiWaze Clear and BiWaze Cough) and the Alpha Ventilator for invasive and non-invasive ventilation. Founded in 2020 and based in Mumbai, the company addresses a critical need in respiratory therapy—a market growing due to rising COPD, asthma, and respiratory infection prevalence. Their technology emphasizes precision pressure control, telehealth integration, and novel approaches to airway management, positioning them to compete with established players like Philips and ResMed in emerging markets. Currently in the commercial stage, ABM has launched products in India and is likely pursuing regulatory approvals (e.g., CE marking) for international expansion. As a private company with no disclosed funding, its growth depends on strategic partnerships and penetration into hospital networks. The company's differentiated portfolio and focus on affordability could drive adoption in price-sensitive markets. However, competition and regulatory timelines remain risks. Overall, ABM is a promising but early-stage player in the respiratory device space.

Upcoming Catalysts (preview)

• Q3 2026CE mark approval for Alpha Ventilator65% success
• Q2 2026Partnership with major Indian hospital chain60% success
• Q4 2026Launch of next-gen BiWaze device with telehealth features70% success